Transition State of Arp2/3 Complex Activation by Actin-Bound Dimeric Nucleation-Promoting Factor.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
15 08 2023
Historique:
pmc-release: 07 02 2024
medline: 9 8 2023
pubmed: 7 8 2023
entrez: 7 8 2023
Statut: ppublish

Résumé

Arp2/3 complex generates branched actin networks that drive fundamental processes such as cell motility and cytokinesis. The complex comprises seven proteins, including actin-related proteins (Arps) 2 and 3 and five scaffolding proteins (ArpC1-ArpC5) that mediate interactions with a pre-existing (mother) actin filament at the branch junction. Arp2/3 complex exists in two main conformations, inactive with the Arps interacting end-to-end and active with the Arps interacting side-by-side like subunits of the short-pitch helix of the actin filament. Several cofactors drive the transition toward the active state, including ATP binding to the Arps, WASP-family nucleation-promoting factors (NPFs), actin monomers, and binding of Arp2/3 complex to the mother filament. The precise contribution of each cofactor to activation is poorly understood. We report the 3.32-Å resolution cryo-electron microscopy structure of a transition state of Arp2/3 complex activation with bound constitutively dimeric NPF. Arp2/3 complex-binding region of the NPF N-WASP was fused C-terminally to the α and β subunits of the CapZ heterodimer. One arm of the NPF dimer binds Arp2 and the other binds actin and Arp3. The conformation of the complex is intermediate between those of inactive and active Arp2/3 complex. Arp2, Arp3, and actin also adopt intermediate conformations between monomeric (G-actin) and filamentous (F-actin) states, but only actin hydrolyzes ATP. In solution, the transition complex is kinetically shifted toward the short-pitch conformation and has higher affinity for F-actin than inactive Arp2/3 complex. The results reveal how all the activating cofactors contribute in a coordinated manner toward Arp2/3 complex activation.

Identifiants

pubmed: 37549294
doi: 10.1073/pnas.2306165120
pmc: PMC10434305
doi:

Substances chimiques

Actins 0
Protein Subunits 0
ACTR2 protein, human 0
ACTR3 protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2306165120

Subventions

Organisme : NIGMS NIH HHS
ID : F31 GM148048
Pays : United States

Références

Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1285-90
pubmed: 23292935
Methods Enzymol. 2010;481:109-26
pubmed: 20887855
Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4265-4274
pubmed: 30760599
Nat Cell Biol. 2001 Jan;3(1):76-82
pubmed: 11146629
Nat Struct Mol Biol. 2013 Sep;20(9):1062-8
pubmed: 23893131
Science. 2001 Nov 23;294(5547):1679-84
pubmed: 11721045
Sci Adv. 2020 Jun 5;6(23):
pubmed: 32917641
Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):E472-9
pubmed: 21676863
Mol Cell. 2004 Oct 22;16(2):269-79
pubmed: 15494313
Annu Rev Biophys. 2011;40:169-86
pubmed: 21314430
J Cell Biol. 2013 Mar 4;200(5):619-33
pubmed: 23439681
Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):E463-71
pubmed: 21676862
Curr Biol. 2022 Mar 14;32(5):975-987.e6
pubmed: 35090589
Nature. 2000 Apr 27;404(6781):1007-11
pubmed: 10801131
Proc Natl Acad Sci U S A. 2016 Jul 5;113(27):E3834-43
pubmed: 27325766
Nature. 2009 Jan 22;457(7228):441-5
pubmed: 19158791
EMBO J. 2018 Nov 15;37(22):
pubmed: 30322896
Nat Struct Mol Biol. 2010 Apr;17(4):497-503
pubmed: 20357771
Proc Natl Acad Sci U S A. 1998 May 26;95(11):6181-6
pubmed: 9600938
Nat Methods. 2008 Jan;5(1):53-5
pubmed: 18157137
J Struct Biol. 2015 Nov;192(2):216-21
pubmed: 26278980
Trends Cell Biol. 2022 May;32(5):421-432
pubmed: 34836783
Nat Methods. 2017 Mar;14(3):290-296
pubmed: 28165473
Nat Rev Mol Cell Biol. 2014 Oct;15(10):677-89
pubmed: 25207437
Nat Commun. 2014;5:3308
pubmed: 24518936
Proc Natl Acad Sci U S A. 2022 May 31;119(22):e2202723119
pubmed: 35622886
Proc Natl Acad Sci U S A. 2022 Dec 6;119(49):e2206722119
pubmed: 36442092
Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3739-44
pubmed: 10097107
Elife. 2013 Sep 03;2:e01008
pubmed: 24015360
Science. 2023 Jun 23;380(6651):1287-1292
pubmed: 37228182
Commun Biol. 2021 Jul 15;4(1):874
pubmed: 34267316
Protein Sci. 2021 Jan;30(1):70-82
pubmed: 32881101
Nat Commun. 2022 Feb 2;13(1):628
pubmed: 35110533
Nat Struct Mol Biol. 2018 Jun;25(6):528-537
pubmed: 29867215
Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16644-9
pubmed: 16275905
Nature. 2018 Feb 7;554(7691):202-206
pubmed: 29420470
Nat Commun. 2021 Sep 9;12(1):5329
pubmed: 34504078
Acta Crystallogr D Struct Biol. 2019 Oct 1;75(Pt 10):861-877
pubmed: 31588918
Trends Biochem Sci. 2016 Jun;41(6):478-490
pubmed: 27068179
Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):3959-3961
pubmed: 30782816
Elife. 2018 Nov 09;7:
pubmed: 30412051
Protein Sci. 2020 Apr;29(4):1069-1078
pubmed: 31730249
EMBO J. 2006 Nov 29;25(23):5626-33
pubmed: 17110933
PLoS Biol. 2004 Apr;2(4):E91
pubmed: 15094799
Mol Cell. 2007 May 11;26(3):449-57
pubmed: 17499050
J Mol Graph Model. 2002 Dec;21(3):181-3
pubmed: 12463636
Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):E8642-E8651
pubmed: 30150414
Nat Methods. 2017 Apr;14(4):331-332
pubmed: 28250466
Chem Biol. 2013 May 23;20(5):701-12
pubmed: 23623350
Nat Cell Biol. 2006 Aug;8(8):826-33
pubmed: 16862144
Nat Commun. 2016 Jul 15;7:12226
pubmed: 27417392
Elife. 2013 Sep 03;2:e00884
pubmed: 24015358
Nat Commun. 2020 Dec 22;11(1):6437
pubmed: 33353942
Nature. 2013 Nov 14;503(7475):281-4
pubmed: 24132237
Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):E1409-E1418
pubmed: 29386393
Nat Commun. 2017 Sep 20;8(1):629
pubmed: 28931821

Auteurs

Trevor van Eeuwen (T)

Biochemistry and Molecular Biophysics Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.

Malgorzata Boczkowska (M)

Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.

Grzegorz Rebowski (G)

Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.

Peter J Carman (PJ)

Biochemistry and Molecular Biophysics Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.

Fred E Fregoso (FE)

Biochemistry and Molecular Biophysics Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.

Roberto Dominguez (R)

Biochemistry and Molecular Biophysics Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH